The disruption of PD-1/SHP2 signaling via genetic ablation or blockade of immune checkpoints adds to myelopoiesis, and macrophage polarization to pro-inflammatory macrophage, and pathological myeloid–T cell interaction leading to atherosclerosis, myocarditis, and vasculitis. This evidence concerns the gene RPL17 and atherosclerosis.